Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05622682 · ClinicalTrials.gov registry record
Vaccine Immune Recovery After Leukemia
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 89
- Enrollment target
NCT05622682 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 89 participants.
The verdict
NCT05622682 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
Study Summary
This observational study aims to assess recovery of the immune system and immunity to vaccine-preventable diseases in children, adolescents, and young adults who recently completed treatment for acute lymphoblastic leukemia (ALL). Several children's hospitals in the United States are participating in the study, which will enroll up to 100 pediatric participants. The study is intended to determine the rate of infection after leukemia treatment and to inform future studies and recommendations about whether children and adolescents who have leukemia should receive additional vaccine doses or boosters after treatment.
Interventions
- OTHER Observational only: Serology and flow cytometry for ALL cohort participants
- OTHER Observational only: Infection rates
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2022-09-28 |
| Est. Completion | 2025-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05622682
The ClinicalTrials.gov registry entry for NCT05622682 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Observational only: Serology and flow cytometry for ALL cohort participants is the first listed.
NCT05622682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05622682 about?
NCT05622682 is a clinical study titled "Vaccine Immune Recovery After Leukemia". This observational study aims to assess recovery of the immune system and immunity to vaccine-preventable diseases in children, adolescents, and young adults who recently completed treatment for acute lymphoblastic leukemia (ALL). Several children's hospitals in the United States are participating i...
What is the current status of trial NCT05622682?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2022-09-28. Estimated completion is 2025-11-30.
What interventions are being tested in trial NCT05622682?
The interventions under investigation include: Observational only: Serology and flow cytometry for ALL cohort participants (OTHER), Observational only: Infection rates (OTHER).
Who is sponsoring clinical trial NCT05622682?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.